Syneos Health (35)
Browse by Contract Category
Contracts
-
Tenth Amendment to the Receivables Financing Agreement, dated as of January 22, 2021, by and among Syneos Health Receivables LLC, as borrower, Syneos Health, LLC, as initial...
(Filed With SEC on February 18, 2021)
-
Fifth Amendment to the Purchase and Sale Agreement, dated as of January 22, 2021, among each of the entities listed on the signature pages hereto as an Originator, Syneos Health,...
(Filed With SEC on February 18, 2021)
-
Form of Global Performance Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan (Non-U.S. Participants)
(Filed With SEC on January 21, 2021)
-
Letter Agreement between Syneos Health UK Limited and Alistair Macdonald, dated May 3, 2019
(Filed With SEC on April 30, 2020)
-
First Amendment to the Purchase and Sale Agreement, dated as of January 2, 2019, among various entities listed on Schedule I thereto, as originators, and Syneos Health, LLC, as...
(Filed With SEC on February 18, 2021)
-
Form of Global Performance Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan (U.S. Participants)
(Filed With SEC on January 21, 2021)
-
Underwriting Agreement, dated December 1, 2020, by and among Syneos Health, Inc., the selling stockholders named therein and Goldman Sachs & Co. LLC and BofA Securities, Inc
(Filed With SEC on December 3, 2020)
-
Indenture, dated as of November 24, 2020, between the Company and Wells Fargo Bank, National Association, as trustee
(Filed With SEC on November 25, 2020)
-
First Supplemental Indenture, dated as of November 24, 2020, between the Company, the subsidiary guarantors named on the signature pages thereto and Wells Fargo Bank, National...
(Filed With SEC on November 25, 2020)
-
Second Amendment to the Purchase and Sale Agreement, dated as of July 25, 2019, among inVentiv Commercial Services, LLC, each of the entities listed on the signature pages as an...
(Filed With SEC on October 29, 2020)
-
Ninth Amendment to the Receivables Financing Agreement, dated as of September 25, 2020, by and among Syneos Health Receivables LLC, as borrower, Syneos Health, LLC, as initial...
(Filed With SEC on October 29, 2020)
-
Fourth Amendment to the Purchase and Sale Agreement, dated as of September 25, 2020, among each of the entities listed on the signature pages as a New Originator, each of the...
(Filed With SEC on October 29, 2020)
-
Stock Purchase Agreement, dated as of October 26, 2020, by and between SHCR Holdings, LLC and Syneos Health Clinical, Inc
(Filed With SEC on October 29, 2020)
-
Underwriting Agreement, dated September 15, 2020, by and among Syneos Health, Inc., the selling stockholders named therein and Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC
(Filed With SEC on September 17, 2020)
-
Form of Director Indemnification Agreement
(Filed With SEC on August 6, 2020)
-
Eighth Amendment to the Receivables Financing Agreement, dated March 18, 2020, among Syneos Health Receivables LLC, as borrower, Syneos Health, LLC as initial servicer, and PNC...
(Filed With SEC on April 30, 2020)
-
Amendment No. 3 to the Credit Agreement, dated as of April 7, 2020, by and between Syneos Health, Inc. as Administrative Borrower and JPMorgan Chase Bank, N.A., as Administrative...
(Filed With SEC on April 30, 2020)
-
Letter Agreement between Syneos Health, Inc. and Jonathan Olefson, dated April 18, 2020
(Filed With SEC on April 22, 2020)
-
Letter Agreement between Syneos Health, Inc. and Michelle Keefe, dated April 18, 2020
(Filed With SEC on April 22, 2020)
-
Letter Agreement between Syneos Health, Inc. and Jason Meggs, dated April 18, 2020
(Filed With SEC on April 22, 2020)
-
Letter Agreement between INC Research Holding Limited and Alistair Macdonald, dated April 18, 2020
(Filed With SEC on April 22, 2020)
-
Letter Agreement between Syneos Health, Inc. and Paul Colvin, dated April 18, 2020
(Filed With SEC on April 22, 2020)
-
Letter Agreement, dated August 29, 2018, by and between Syneos Health, Inc. and Paul D. Colvin
(Filed With SEC on February 20, 2020)
-
Omnibus Amendment, dated January 31, 2020, that is the Third Amendment to the Purchase and Sale Agreement and the Seventh Amendment to the Receivables Financing Agreement, among...
(Filed With SEC on February 20, 2020)
-
Amendment Two to the Executive Service Agreement, made as of January 15, 2020, between INC Research Holding Limited and Alistair Macdonald
(Filed With SEC on February 20, 2020)
-
Letter Agreement, dated November 7, 2017, by and between INC Research/inVentiv Health and Michelle Keefe
(Filed With SEC on February 20, 2020)
-
Management Incentive Plan
(Filed With SEC on February 20, 2020)
-
Description of Capital Stock
(Filed With SEC on February 20, 2020)
-
Form of Amendment No. 2 to Executive Service Agreement between Alistair Macdonald and INC Research Holding Limited, dated January 15, 2020
(Filed With SEC on January 17, 2020)
-
Sixth Amendment to the Receivables Financing Agreement, dated September 30, 2019, among Syneos Health Receivables LLC, as borrow
(Filed With SEC on October 31, 2019)
-
Fourth Amendment to the Receivables Financing Agreement, dated January 2, 2019, among Syneos Health Receivables LLC, as borrow, PNC Bank, National Association, as administrative...
(Filed With SEC on August 6, 2019)
-
Fifth Amendment to the Receivables Financing Agreement, dated July 25, 2019, among Syneos Health Receivables LLC, as borrow, PNC Bank, National Association, as administrative...
(Filed With SEC on August 6, 2019)
-
Form of Global Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan
(Filed With SEC on March 18, 2019)
-
Form of Global Performance Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan
(Filed With SEC on March 18, 2019)
-
Letter Agreement, dated November 13, 2018, by and among Syneos Health, Inc. and Jonathan Olefson
(Filed With SEC on March 18, 2019)